Benzinga | Jul 29, 2021 08:08AM EDT

BTIG Initiates Coverage On BELLUS Health with Buy Rating, Announces Price Target of $9

BTIG analyst Justin Zelin initiates coverage on BELLUS Health (NASDAQ:BLU) with a Buy rating and announces Price Target of $9.